TD ASSET MANAGEMENT INC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$432,708
-13.1%
10,7000.0%0.00%0.0%
Q4 2022$497,764
-11.3%
10,7000.0%0.00%0.0%
Q3 2022$561,000
+16.4%
10,700
+4.9%
0.00%0.0%
Q2 2022$482,000
-49.1%
10,200
-23.3%
0.00%0.0%
Q1 2022$947,000
-50.3%
13,300
-47.8%
0.00%
-50.0%
Q4 2021$1,907,000
+76.7%
25,500
+34.2%
0.00%
+100.0%
Q3 2021$1,079,000
+22.6%
19,000
+6.5%
0.00%0.0%
Q1 2021$880,000
-9.7%
17,847
-22.9%
0.00%0.0%
Q4 2020$974,000
-8.1%
23,1470.0%0.00%0.0%
Q3 2020$1,060,000
-27.8%
23,147
-20.9%
0.00%
-50.0%
Q2 2020$1,468,000
+0.3%
29,247
+2.8%
0.00%0.0%
Q1 2020$1,463,000
-28.4%
28,447
-13.9%
0.00%
-33.3%
Q4 2019$2,042,000
-6.5%
33,047
-9.1%
0.00%0.0%
Q3 2019$2,184,000
-32.9%
36,347
-5.7%
0.00%
-40.0%
Q2 2019$3,253,000
-3.1%
38,548
+9.7%
0.01%0.0%
Q1 2019$3,357,000
+48.9%
35,148
+10.5%
0.01%
+25.0%
Q4 2018$2,254,000
-16.7%
31,817
+0.5%
0.00%0.0%
Q3 2018$2,707,000
-42.7%
31,672
-22.3%
0.00%
-42.9%
Q2 2018$4,724,000
+334.2%
40,761
+203.2%
0.01%
+250.0%
Q1 2018$1,088,000
+41.1%
13,442
+2.3%
0.00%
+100.0%
Q4 2017$771,00013,1340.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 476,042$45,472,00012.29%
Stonepine Capital Management, LLC 60,840$5,811,0003.34%
ACUTA CAPITAL PARTNERS, LLC 61,000$5,827,0002.77%
Virtus ETF Advisers LLC 10,634$1,016,0002.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,000$5,827,0002.15%
ARMISTICE CAPITAL, LLC 372,000$35,533,0001.94%
Matarin Capital Management, LLC 209,403$20,002,0001.46%
Monashee Investment Management LLC 50,000$4,776,0001.10%
Granahan Investment Management 151,322$14,454,0000.78%
ALGERT GLOBAL LLC 13,186$1,260,0000.72%
View complete list of ENANTA PHARMACEUTICALS INC shareholders